Month: October 2019
As the public debate on health reform rolls on, a new report from Moody’s Investors Service analyzes how these different approaches could impact insurers’ bottom lines.
The top Republican on the House Ways and Means Committee on Wednesday rejected a proposal from the Democratic chairman of the panel to protect patients from surprise medical bills, saying a different approach is needed to solve the problem.
A new state law going into effect Jan. 1 requires Californians to have health insurance in 2020 or face a penalty on their state taxes.
California Governor Gavin Newsom today signed the biggest prescription drug price bill of the year, intended to lower prescription drug prices for California consumers by hundreds of millions of dollars a year. During the first-ever health care bill signing event under the new Administration, Newsom signed AB 824
Drugmakers fought hard against California’s groundbreaking drug price transparency law, passed in 2017. Now, state health officials have released their first report on the price hikes those drug companies sought to shield.
If you tuned in for the first five nights of the Democratic presidential debates, you might think “Medicare for All” and providing universal care are the only health care ideas Democrats have.
Open enrollment for Covered California, the state marketplace that sells subsidized health insurance to Californians who do not get insurance through their employer, begins Tuesday and ends Jan. 31.
Support is dropping for Sen. Bernie Sanders "Medicare for All" health care plan, according to a poll released Tuesday.
House Speaker Nancy Pelosi’s drug prices plan would reduce Medicare spending by $345 billion over a seven-year period but could also impact the number of new drugs entering the market, according to an analysis from the Congressional Budget Office.
A decision in the latest court case to threaten the future of the Affordable Care Act could come as soon as this month. The ruling will come from the panel of judges in the 5th Circuit Court of Appeals, which heard oral arguments in the Texas v. Azar lawsuit.